Powered by: Motilal Oswal
2026-09-21 11:12:54 am | Source: Religare Broking Ltd
Trade Idea of The Day - Max Healthcare Institute Ltd Target Rs. 35 - Religare Broking Ltd
Trade Idea of The Day - Max Healthcare Institute Ltd Target Rs. 35 - Religare Broking Ltd

Max Healthcare Institute Ltd

BUY 29 SEP 1050 CALL Entry Range 12 -15 Target 35 Stop Loss 6.5

Rationale

• MAXHEALTH has maintained a positive structure on the daily chart, as the stock has recently reclaimed its key moving averages of the 20-DEMA as well as the 50-DEMA, indicating improving buying interest and strengthening momentum.

• The stock has taken support near its rising trendline, as the stock price has formed a higher bottom structure on the daily timeframe. Sustained trading above the 1,020-10350 zone keeps the broader bullish structure intact and provides a favorable base for further upside.

• Momentum indicators are supportive, with RSI hovering near the 60 mark and moving higher, while the MACD has turned positive with a bullish crossover, indicating strengthening momentum and scope for continuation of the recent recovery.

• On the upside, sustained buying above the immediate support zone could trigger a move towards 1,090-1,100, followed by 1,140. Any dip towards the support zone may attract fresh buying interest, and the 980 -1,000 zone holds strong downside support.

 

Please refer disclaimer at https://www.religareonline.com/disclaimer

SEBI Registration number is INZ00017433

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here